menu close
www.dispatchbio.com

Dispatch Bio Stock

Company Profile:

Dispatch Bio is biotechnology company engineering a universal immunotherapy platform that tags solid tumor cells with a synthetic antigen via a viral vector and then directs immune cells to selectively eliminate them. It combines tumor-specific delivery and microenvironment modulation to overcome resistance and enable immunotherapy across multiple solid tumor types .

Sign up for SecondMarket® to view the market and buy or sell Dispatch Bio Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Dispatch Bio Funding

Sign up to gain insights into Dispatch Bio funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Financing Round Date Amount Price per share* Valuation*
Series A Jul 23, 2025 114.00M
Price
Valuation
Series Seed Jul 23, 2025 65.79M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®

Leverage Your Equity to Help Achieve More.

Dispatch Bio Management Team

  • CEO

    Sabah Oney

  • Chief Scientific Officer

    Barbara Sasu

Dispatch Bio Major Investors

  • Alexandria Venture Investments

  • University of Pennsylvania

  • Bristol Myers Squibb

  • Stanford University

  • The Parker Institute for Cancer Immunotherapy

  • ARCH Venture Partners

Learn More About Dispatch Bio Stock

Buy Dispatch Bio Stock
01

Dispatch Bio stock does not trade on public stock exchanges. Dispatch Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Dispatch Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Dispatch Bio Stock
02

Dispatch Bio Stock does not trade on public stock exchanges. In order to sell Dispatch Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Dispatch Bio Stock Price
03

Dispatch Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Dispatch Bio share price and other valuable private market data.

Read more about secondary market private company stock prices:

Dispatch Bio Stock Ticker Symbol
04

There is no ticker symbol for Dispatch Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Dispatch Bio Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Dispatch Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Dispatch Bio Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Dispatch Bio stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Dispatch Bio Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Dispatch Bio IPO
08

Dispatch Bio is a private company and has not had an IPO. There is currently no Dispatch Bio IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Dispatch Bio IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket® to view the market and buy or sell Dispatch Bio Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Tessera Therapeutics-Logo

Tessera Therapeutics

Genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source.

Arsenalbio-Logo

ArsenalBio

Develops programmable cell therapies for cancer patients.

Source: Nasdaq Private Market Tape D®